US ophthalmologists plead with drug regulator not to restrict access to Avastin.
The BMJ.
Deborah
D
Cohen
D020533:Angiogenesis Inhibitors / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D000068258:Bevacizumab; D004339:Drug Compounding; D004340:Drug Contamination; D004349:Drug Packaging; D004335:Drug and Narcotic Control; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D056687:Off-Label Use; D009885:Ophthalmology; D014481:United States; D014486:United States Food and Drug Administration
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab